Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platformResearch in context

Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platformResearch in context

Summary: Background: Plasma phospho-tau 217 (pTau217) assays can accurately detect Alzheimer's disease (AD) pathology, but clinical application is limited by the need for specialised equipment. This study tests the performance of a plasma pTau217 assay performed on the Lumipulse-G® platform, t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Azadeh Feizpour, James David Doecke, Vincent Doré, Natasha Krishnadas, Kun Huang, Pierrick Bourgeat, Simon Matthew Laws, Christopher Fowler, Joanne Robertson, Lucy Mackintosh, Scott Ayton, Ralph Martins, Stephanie Ruth Rainey-Smith, Kevin Taddei, Larry Ward, Eddie Stage, Anthony Wilson Bannon, Colin Louis Masters, Jurgen Fripp, Victor Luis Villemagne, Christopher Cleon Rowe
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Series:	EBioMedicine
Subjects:	Alzheimer's disease Plasma biomarker Phospho-tau pTau217 Positron emission tomography PET
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396424004419
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TOMM40 may mediate GFAP, neurofilament light Protein, pTau181, and brain morphometry in aging
by: Robyn A. Honea, et al.
Published: (2025-01-01)

Understanding retinal tau pathology through functional 2D and 3D iPSC-derived in vitro retinal models
by: Lorenza Mautone, et al.
Published: (2025-01-01)

Cerebrospinal Fluid Classical Biomarker Levels in Mixed vs. Pure A<sup>+</sup>T<sup>+</sup> (A<sup>+</sup>T<sub>1</sub><sup>+</sup>) Alzheimer’s Disease
by: Ioanna Tsantzali, et al.
Published: (2024-12-01)

Correlations Between Cerebrospinal Fluid Biomarkers Concentration and Severity of Cognitive Impairment in Alzheimer Disease
by: Joanna Tarasiuk, et al.
Published: (2018-06-01)

pTau pathology in the retina of TAU58 mice: association with ganglion cell degeneration and implications on seeding and propagation of pTau from human brain lysates
by: Grzegorz Walkiewicz, et al.
Published: (2024-12-01)

PtAu catalyst with enhanced activity for formic acid oxidation
by: Jelena R. Rogan, et al.
Published: (2018-06-01)

Distribution of β-amyloid and pTau in brain cortex depending on age and mental state
by: Alexandra V. Sentyabreva, et al.
Published: (2024-12-01)

Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217
by: Branislav Kovacech, et al.
Published: (2024-11-01)

Identification of late-stage tau accumulation using plasma phospho-tau217Research in context
by: Marcel S. Woo, et al.
Published: (2024-11-01)

Plasma phospho-tau217 as a predictive biomarker for Alzheimer’s disease in a large south American cohort
by: Neetesh Pandey, et al.
Published: (2025-01-01)

Analytical and clinical performance of eight Simoa® and Lumipulse® assays for automated measurement of plasma p-tau181 and p-tau217
by: Anna L. Wojdała, et al.
Published: (2024-12-01)

Longitudinal trajectory of plasma p-tau217 in cognitively unimpaired subjects
by: Francisco Martínez-Dubarbie, et al.
Published: (2024-12-01)

Tau Protein and β-Amyloid Associated with Neurodegeneration in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis (EAE), a Mouse Model of Multiple Sclerosis
by: Grażyna Pyka-Fościak, et al.
Published: (2024-12-01)

Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
by: Futao Zhou, et al.
Published: (2024-10-01)

Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease
by: Linda J. Van Eldik, et al.
Published: (2024-10-01)

Fabrication of Pb-Containing PtAu Nanoflowers via Galvanic Replacement Method for Electrocatalytical Oxidation of Methanol
by: Zhao Huang, et al.
Published: (2024-11-01)

Traditional Chinese medicine in Alzheimer's disease: From the perspective of GSK-3β and Tau hyperphosphorylation
by: Mei Wang, et al.
Published: (2024-12-01)

Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β
by: Mei Wang, et al.
Published: (2025-02-01)

Molecular mechanism of anti-luteolysis during the maternal recognition of pregnancy in cows
by: Aydın Güzeloğlu

Rivastigmine interferes with the pharmacological activity of hydromethylthionine on presynaptic proteins in the line 66 model of frontotemporal dementia
by: Karima Schwab, et al.
Published: (2025-01-01)

Search for bottom quark associated production of the standard model Higgs boson in final states with leptons in proton-proton collisions at s=13TeV
by: A. Hayrapetyan, et al.
Published: (2025-01-01)

Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model
by: Douglas M. Lopes, et al.
Published: (2024-04-01)

Test of light-lepton universality in τ decays with the Belle II experiment
by: The Belle II collaboration, et al.
Published: (2024-08-01)

Hyperphosphorylated tau targeting human serum albumin Fusion protein as therapeutics for Alzheimer’s diseases
by: Sookhee Bang, et al.
Published: (2024-12-01)

Late-Life Alcohol Exposure Does Not Exacerbate Age-Dependent Reductions in Mouse Spatial Memory and Brain TFEB Activity
by: Hao Chen, et al.
Published: (2024-11-01)

Dynamic regimes in planetary cores: $\tau $–$\ell $ diagrams
by: Nataf, Henri-Claude, et al.
Published: (2024-05-01)

Evaluating the Efficacy of Levetiracetam on Non-Cognitive Symptoms and Pathology in a Tau Mouse Model
by: Jackson C. Thompson, et al.
Published: (2024-12-01)

On a function related to Ramanujan's Tau function
by: John A. Ewell
Published: (1985-01-01)

Depression like-behavior and memory loss induced by methylglyoxal is associated with tryptophan depletion and oxidative stress: a new in vivo model of neurodegeneration
by: Md. Samsuzzaman, et al.
Published: (2024-11-01)

Effect of calcium ions on the aggregation of highly phosphorylated tau
by: Toru Tanaka, et al.
Published: (2024-12-01)

Spontaneous and perturbation-based EEG cortical excitability markers are associated with plasma p-tau181 concentration in healthy middle-aged adults
by: Ruben Perellón-Alfonso, et al.
Published: (2024-12-01)

Comprehensive review on Alzheimer's disease: From the posttranslational modifications of Tau to corresponding treatments
by: Xin Li, et al.
Published: (2024-12-01)

Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
by: Geetika Nehra, et al.
Published: (2025-01-01)

Truncated tau disrupts autophagy and endolysosomal systems
by: Saskia J. Pollack, et al.
Published: (2024-12-01)

Survey among experts on the future role of tau‐PET in clinical practice and trials
by: Marie R. Vermeiren, et al.
Published: (2024-10-01)

SUMO2 rescues neuronal and glial cells from the toxicity of P301L Tau mutant
by: Franca Orsini, et al.
Published: (2024-12-01)

Pragmatic algorithm for visual assessment of 4-Repeat tauopathies in [18F]PI-2620 PET Scans
by: Theresa Bauer, et al.
Published: (2025-02-01)

Search for lepton-flavor-violating τ − → μ − μ + μ − decays at Belle II
by: The Belle II collaboration, et al.
Published: (2024-09-01)

Excess Ub-K48 Induces Neuronal Apoptosis in Alzheimer’s Disease
by: Qiang Li, et al.
Published: (2024-12-01)

VCP regulates early tau seed amplification via specific cofactors
by: Sushobhna Batra, et al.
Published: (2025-01-01)